PepMix™ Peptide Pools

Overlapping peptide pools (peptide mixes of overlapping peptide scans from  virus or tumor antigens such as CMV peptide pools, HPV peptide pools or HIV peptide pools) or mixed antigenic peptide pools (e.g. CEF Mixes with antigens from CMV, EBV and Influenza) are extremely efficient for antigen-specific T-cell stimulation, T-cell expansion, immune monitoring, cellular immune response profiling or  T-cell epitope identification.
Additionally, peptide pools such as the CEF mix or the pp65 peptide pool can be used to standardize T-cell assays, as synthetic pooled peptides are much more robust and reliable for T-cell stimulation (e.g. in ELISPOT, ICS, cytotoxity  or proliferation assays) than proteins or lysates.

Control Peptide Pools for T-cell Assays

CEF Pool (extended) Positive Control Pool of 32 peptides peptides selected from defined HLA class I-restricted T-cell epitopes for T cell assays (e.g. ELISPOT)Info
CEF Pool (standard) (120nmol) Positive Control Pool of 23 peptides peptides selected from defined HLA class I-restricted T-cell epitopes for T cell assays (antigen specific T-cell stimulation)Info
CEF Pool (standard) (15nmol) Positive Control Pool of 23 peptides peptides selected from defined HLA class I-restricted T-cell epitopes for T cell assays (e.g. ELISPOT)Info
CEFT MHCII Pool Pool of 14 peptides peptides selected from defined HLA class II-restricted T-cell epitopes for T cell assays (e.g. antigen specific T-cell stimulation)Info
CEFT Pool Positive Control Pool of 27 peptides peptides selected from defined HLA class I and II-restricted T-cell epitopes for T cell assays (e.g. ELISPOT)Info
EF Pool Positive Control Pool of 20 peptides peptides selected from defined HLA class I-restricted T-cell epitopes for T cell assays (e.g. ELISPOT)Info
Negative Control Pool PepMix™ HIV-1 (Con B gag motif) Negative Control Pool of 123 peptides selected from Con B gag motifs of Human immunodeficiency virus strainsInfo
PepMix™ Human (Actin) Negative Control Pool of 120 peptides derived from a peptide scan through Actin, alpha skeletal muscle of Homo sapiens (Human) for T cell assaysInfo
PepMix™ Human (HLA classI Ig-like C1 type domain) Negative Control Pool of 19 peptides derived from a peptide scan through HLA class I histocompatibility antigen, A-36 alpha chain of Homo sapiensInfo
PepMix™ Human (MOG) Negative Control Pool of 29 peptides derived from a peptide scan through Myelin-oligodendrocyte glycoprotein (MOG) of Homo sapiens (Human)Info
Positive Control Pool PepMix™ HCMVA (IE-1) Positive Control Pool of 120 peptides derived from a peptide scan through 55 kDa immediate-early protein 1 (IE-1) of Human cytomegalovirus (HHV-5)Info
Positive Control Pool PepMix™ HCMVA (IE-2) Positive Control Pool of 143 peptides derived from a peptide scan through 45 kDa immediate-early protein 2 (IE-2) of Human cytomegalovirus (HHV-5).Info
Positive Control Pool PepMix™ HCMVA (pp65) Positive Control Pool of 138 peptides derived from a peptide scan through 65 kDa phosphoprotein (pp65) of Human cytomegalovirus (HHV-5)Info

Peptide Pools for Infectious Diseases Antigens

Negative Control Pool PepMix™ HIV-1 (Con B gag motif) Negative Control Pool of 123 peptides selected from Con B gag motifs of Human immunodeficiency virus strainsInfo
PepMix™ AAV6 (Capsid protein VP1) Pool of 182 overlapping peptides from Capsid protein VP1 of Adeno-associated virus 6 for T cell assays (antigen specific T-cell stimulation)Info
PepMix™ BKV (capsid protein VP1) Pool of 88 peptides derived from a peptide scan through Major capsid protein VP1 of BK polyomavirus for T cell assays (e.g. ELISPOT)Info
PepMix™ BKV (capsid protein VP2) Pool of 85 peptides derived from a peptide scan through Minor capsid protein VP2 of BK polyomavirus for T cell assays (e.g. ELISPOT)Info
PepMix™ BKV (capsid protein VP2, isoform VP3) Pool of 56 peptides derived from a peptide scan through Minor capsid protein VP2, isoform VP3 of BK polyomavirus for T cell assaysInfo
PepMix™ BKV (large T antigen) Pool of 170 peptides derived from a peptide scan through Large T antigen of BK polyomavirus for T cell assays (antigen specific T-cell stimulation)Info
PepMix™ BKV (small T antigen) Pool of 41 peptides derived from a peptide scan through Small t antigen of BK polyomavirus for T cell assays (e.g. antigen specific T-cell stimulation)Info
PepMix™ Candida (MP65) Pool of 92 peptides derived from a peptide scan through Mannoprotein MP65 of Candida albicans (Yeast) for T cell assays (e.g. ELISPOT)Info
PepMix™ Collection EBV Collection of 13 peptide pools through 13 immunodominant antigens of Epstein-Barr virus (EBV)Info
PepMix™ Collection HCMV Collection of 19 peptide pools derived from scans through 19 immuonodominant antigens of Human cytomegalovirus (HHV-5)Info
PepMix™ EBV (BARF1) Pool of 53 overlapping peptides from Secreted protein BARF1 (p53) of Epstein-Barr virus (EBV) for T cell assays (e.g. ELISPOT)Info
PepMix™ EBV (BMLF1) Pool of 117 peptides derived from a peptide scan through mRNA export factor EB2 (BMLF1) of Epstein-Barr virus (HHV4) for T cell assaysInfo
PepMix™ EBV (BMRF1) Pool of 99 peptides derived from a peptide scan through DNA polymerase processivity factor BMRF1 of Epstein-Barr virus (HHV4) for T cell assaysInfo
PepMix™ EBV (BRLF1) Pool of 149 peptides derived from a peptide scan through Transcription activator BRLF1 of Epstein-Barr virus (HHV4) for T cell assaysInfo
PepMix™ EBV (BZLF1) Pool of 59 peptides derived from a peptide scan through Trans-activator protein BZLF1 of Epstein-Barr virus (HHV4) for T cell assaysInfo
PepMix™ EBV (EBNA-LP) Pool of 124 peptides derived from a peptide scan through Epstein-Barr nuclear antigen leader protein (EBNA-LP) of Epstein-Barr virus (HHV4)Info
PepMix™ EBV (EBNA1) Pool of 158 peptides derived from a peptide scan through Epstein-Barr nuclear antigen 1 (EBNA1) of Epstein-Barr virus (HHV4) for T cell assaysInfo
PepMix™ EBV (EBNA2) Pool of 119 peptides derived from a peptide scan through Epstein-Barr nuclear antigen 2 (EBNA2) of Epstein-Barr virus (HHV4) for T cell assaysInfo
PepMix™ EBV (EBNA3a) Pool of 234 peptides derived from a peptide scan through Epstein-Barr nuclear antigen 3 (EBNA3a) of Epstein-Barr virus (HHV4) for T cell assaysInfo
PepMix™ EBV (EBNA3b) Pool of 279 peptides derived from a peptide scan through Epstein-Barr nuclear antigen 4 (EBNA3b) of Epstein-Barr virus (HHV4) for T cell assaysInfo
PepMix™ EBV (EBNA3c) Pool of 265 peptides derived from a peptide scan through Epstein-Barr nuclear antigen 6 (EBNA3c) of Epstein-Barr virus (HHV4) for T cell assaysInfo
PepMix™ EBV (GP350/GP340) Pool of 224 peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope glycoprotein GP350/GP340 of Epstein-Barr virus (HHV4)Info
PepMix™ EBV (LMP1) Pool of 94 peptides derived from a peptide scan through Latent membrane protein 1 (LMP1) of Epstein-Barr virus (HHV4) for T cell assaysInfo
PepMix™ EBV (LMP2) Pool of 122 peptides derived from a peptide scan through Latent membrane protein 2 (LMP2) of Epstein-Barr virus (HHV4) for T cell assaysInfo
PepMix™ HAdV-3 (hexon protein) Pool of 234 peptides derived from a peptide scan through Hexon protein of Human adenovirus 3 (HAdV-3) for T cell assays (e.g. ELISPOT)Info
PepMix™ HAdV-5 (penton protein) Pool of 140 peptides derived from a peptide scan through Penton protein of Human adenovirus 5 (HAdV-5) for T cell assays (e.g. ELISPOT)Info
PepMix™ HBV (Capsid protein) Pool of 44 peptides derived from a peptide scan through Capsid protein of Hepatitis B virus (HBV-A) for T cell assays (e.g. ELISPOT)Info
PepMix™ HBV (Large envelope protein) Pool of 98 peptides derived from a peptide scan through Large envelope protein of Hepatitis B virus (HBV-A) for T cell assays (e.g. ELISPOT)Info
PepMix™ HCMVA (UL103) Pool of 60 peptides derived from a peptide scan through Protein UL103 of Human cytomegalovirus (HHV-5) for T cell assays (e.g. ELISPOT)Info
PepMix™ HCMVA (UL151) Pool of 82 peptides derived from a peptide scan through Orf UL151 of Human cytomegalovirus (HHV-5) for T cell assays (e.g. ELISPOT)Info
PepMix™ HCMVA (UL153) Pool of 67 peptides derived from a peptide scan through Orf UL153 of Human cytomegalovirus (HHV-5) for T cell assays (e.g. ELISPOT)Info
PepMix™ HCMVA (UL28) Pool of 92 peptides derived from a peptide scan through Uncharacterized protein UL28 of Human cytomegalovirus (HHV-5) for T cell assaysInfo
PepMix™ HCMVA (UL32) Pool of 260 peptides derived from a peptide scan through Large structural phosphoprotein (UL32) of Human cytomegalovirus (HHV-5) for T cell assaysInfo
PepMix™ HCMVA (UL36) Pool of 117 peptides derived from a peptide scan through Uncharacterized protein UL36 of Human cytomegalovirus (HHV-5) for T cell assaysInfo
PepMix™ HCMVA (UL40) Pool of 53 peptides derived from a peptide scan through Uncharacterized protein UL40 of Human cytomegalovirus (HHV-5) for T cell assaysInfo
PepMix™ HCMVA (UL48)_ 2 subpools Pool of 2 x 281 peptides derived from a peptide scan through Deneddylase UL48 of Human cytomegalovirus (HHV-5) for T cell assaysInfo
PepMix™ HCMVA (UL55) Pool of 224 peptides derived from a peptide scan through Envelope glycoprotein B (UL55) of Human cytomegalovirus (HHV-5) for T cell assaysInfo
PepMix™ HCMVA (UL82) Pool of 137 peptides derived from a peptide scan through 71 kDa phosphoprotein (UL82) of Human cytomegalovirus (HHV-5) for T cell assaysInfo
PepMix™ HCMVA (UL94) Pool of 84 peptides derived from a peptide scan through Capsid-binding protein UL94 of Human cytomegalovirus (HHV-5) for T cell assaysInfo
PepMix™ HCMVA (UL99) Pool of 45 peptides derived from a peptide scan through Tegument protein UL99 of Human cytomegalovirus (HHV-5) for T cell assays (e.g. ELISPOT)Info
PepMix™ HCMVA (US24) Pool of 123 peptides derived from a peptide scan through Tegument protein US24 of Human cytomegalovirus (HHV-5) for T cell assaysInfo
PepMix™ HCMVA (US29) Pool of 113 peptides derived from a peptide scan through Uncharacterized protein HHRF4 (US29) of Human cytomegalovirus (HHV-5) for T cell assaysInfo
PepMix™ HCMVA (US3) Pool of 44 peptides derived from a peptide scan through Unique short US3 glycoprotein of Human cytomegalovirus (HHV-5) for T cell assaysInfo
PepMix™ HCMVA (US32) Pool of 43 peptides derived from a peptide scan through Uncharacterized protein HHRF7 (US32) of Human cytomegalovirus (HHV-5) for T cell assaysInfo
PepMix™ HEV (ORF2) Pool of 163 peptides derived from a peptide scan (15mers with 11 aa overlap) through Capsid protein (UniProt ID: E9N3B9) of Hepatitis E virus (strain Kernow-C1)Info
PepMix™ HEV (ORF3) Pool of 26 peptides derived from a peptide scan (15mers with 11 aa overlap) through Uncharacterized protein ORF 3 (UniProt ID: E9N3B8) of Hepatitis E virus (strain Kernow-C1)Info
PepMix™ HHV (U90) Pool of 267 peptides derived from a peptide scan through Protein U90 of Human herpesvirus 6B for T cell assays (antigen specific T-cell stimulation)Info
PepMix™ HHV2 (VP22) Pool of 73 peptides derived from a peptide scan (15mers with 11 aa overlap) through Tegument protein VP22 (UniProt ID: P89468) of Human herpesvirus 2 (strain HG52)Info
PepMix™ HHV6 (U54) Pool of 112 peptides derived from a peptide scan through U54 of Human herpesvirus 6B for T cell assays (antigen specific T-cell stimulation)Info
PepMix™ HIV (ENV) Ultra Pool of 150 15meric peptides derived from Envelope glycoprotein gp160 designed to cover the high sequence diversity of the HI virus for T cell assaysInfo
PepMix™ HIV (GAG) Ultra Pool of 150 15meric peptides derived from Gag polyprotein designed to cover the high sequence diversity of the HIV virus for T cell assays (e.g. ELISPOT)Info
PepMix™ HIV (NEF) Ultra Pool of 150 15meric peptides derived from Nef protein designed to cover the high sequence diversity of the HI virus for T cell assays (e.g. ELISPOT)Info
PepMix™ HIV (POL) Ultra Pool of 150 15meric peptides derived from Pol Polyprotein designed to cover the high sequence diversity of the HI virus for T cell assaysInfo
PepMix™ HPV 16 (Protein E6) Pool of 37 peptides derived from a peptide scan through Protein E6 of Human papillomavirus type 16 for T cell assays (e.g. ELISPOT)Info
PepMix™ HPV 16 (Protein E7) Pool of 22 peptides derived from a peptide scan through Protein E7 of Human papillomavirus type 16 for T cell assays (e.g. ELISPOT)Info
PepMix™ HPV 18 (Protein E6) Pool of 37 peptides derived from a peptide scan through Protein E6 of Human papillomavirus type 18 for T cell assays (e.g. ELISPOT)Info
PepMix™ HPV 18 (Protein E7) Pool of 24 peptides derived from a peptide scan through Protein E7 of Human papillomavirus type 18 for T cell assays (e.g. ELISPOT)Info
PepMix™ HPV16 (L1) Pool of 124 overlapping peptides from Late major capsid protein L1 (L1) of Human papillomavirus type 16 (HPV) for T cell assays (e.g. ELISPOT)Info
PepMix™ Human (Kir4.1) Pool of 92 peptides derived from a peptide scan (15mers with 11 aa overlap) through Kir4.1 (ATP-sensitive inward rectifier potassium channel 10, UniProt ID: P78508) of Homo sapiens.Info
PepMix™ Influenza A (HA /Brisbane (H1N1)) Pool of 139 peptides derived from a peptide scan through Hemagglutinin of Influenza A virus (A/Brisbane/59/2007(H1N1)) for T cell assaysInfo
PepMix™ Influenza A (HA /California (H1N1)) Pool of 139 peptides derived from a peptide scan through Hemagglutinin of Influenza A virus (A/California/07/2009(H1N1)) for T cell assaysInfo
PepMix™ Influenza A (HA/Indonesia (H5N1)) Pool of 140 peptides derived from a peptide scan (15mers with 11 aa overlap) through Hemagglutinin (UniProt ID: A1BK62) of Influenza A virus (Indonesia (H5N1))Info
PepMix™ Influenza A (MP1 (H3N2)) Pool of 110 peptides derived from a peptide scan through Matrix protein 1 of Influenza A virus (strain A/Aichi/2/1968 H3N2) for T cell assaysInfo
PepMix™ Influenza A (MP1 /California (H1N1)) Pool of 61 peptides derived from a peptide scan through Matrix protein 1 of Influenza A virus (A/California/08/2009(H1N1)) for T cell assaysInfo
PepMix™ Influenza A (MP1/AnnArbor (H2N2) Pool of 61 overlapping peptides from Matrix protein 1 (MP1) of Influenza A (H2N2) for T cell assays (e.g. ELISPOT)Info
PepMix™ Influenza A (MP2 /California (H1N1)) Pool of 22 peptides derived from a peptide scan through Matrix protein 2 of Influenza A virus (A/California/08/2009(H1N1)) for T cell assaysInfo
PepMix™ Influenza A (MP2/AnnArbor (H2N2) Pool of 22 overlapping peptides from Matrix protein 2 (MP2) of Influenza A (H2N2) for T cell assays (e.g. ELISPOT)Info
PepMix™ Influenza A (Neuraminidase/Turkey/1/2005(H5N1)) Pool of 110 peptides derived from a peptide scan through Neuraminidase of Influenza A for T cell assays (antigen specific T-cell stimulation)Info
PepMix™ Influenza A (Neuroamidase /California (H1N1) Pool of 115 peptides derived from a peptide scan through Neuraminidase of Influenza A virus (A/California/08/2009(H1N1)) for T cell assaysInfo
PepMix™ Influenza A (NP (H3N2)) Pool of 122 peptides derived from a peptide scan through Nucleocapsid protein of Influenza A virus (strain A/Kitakyushu/159/1993 H3N2) for T cell assaysInfo
PepMix™ Influenza A (NP/AnnArbor (H2N2) Pool of 122 overlapping peptides from Nucleoprotein (NP) of Influenza A (H2N2) for T cell assays (e.g. ELISPOT)Info
PepMix™ RSV (Fusion glycoprotein F0) Pool of 141 peptides derived from a peptide scan through Fusion glycoprotein F0 of Human respiratory syncytial virus for T cell assays (e.g. ELISPOT)Info
PepMix™ RSV (G glycoprotein) Pool of 72 overlapping peptides from Major surface glycoprotein G (mG) of Human respiratory syncytial virus (RSV) for T cell assaysInfo
PepMix™ RSV (nucleocapsid protein N) Pool of 95 peptides derived from a peptide scan through Nucleoprotein N of Human respiratory syncytial virus for T cell assays (e.g. ELISPOT)Info
PepMix™ VACV (Cell surface-binding protein, MVA105L) Pool of 74 peptides derived from a peptide scan through Cell surface-binding protein (MVA105L) of Vaccinia virus (strain Ankara) for T cell assaysInfo
PepMix™ VACV (Host range protein 2, MVA018L) Pool of 35 peptides derived from a peptide scan through Host range protein 2 (MVA018L) of Vaccinia virus (strain Ankara) for T cell assayInfo
PepMix™ VACV (L3L) Pool of 85 peptides derived from a peptide scan through Protein L3 of Vaccinia Virus (strain WR) for T cell assays (e.g. ELISPOT)Info
PepMix™ VACV (Major core protein P4a, MVA 121L)_2 Subpools Pool of 223 peptides (delivered in two subpools of 112 + 111 peptides) derived from a peptide scan through Major core protein P4a of Vaccinia virusInfo
PepMix™ VACV (MVA 074R) Pool of 106 peptides derived from a peptide scan through Putative 49.8k protein (MVA 074R) of Vaccinia virus (strain Ankara) for T cell assaysInfo
PepMix™ VACV (MVA093L) Pool of 79 peptides derived from a peptide scan through IMV heparin binding surface protein (MVA093L) of Vaccinia virus (strain Ankara) for T cell assaysInfo
PepMix™ VACV (MVA189R) Pool of 45 peptides derived from a peptide scan through Putative 21.7k protein (MVA189R) of Vaccinia virus (strain Ankara) for T cell assaysInfo
PepMix™ VZV (gE) Pool of 153 peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope glycoprotein E (UniProt ID: P09259) of Varicella-zoster virus (strain Dumas) (HHV-3) (Human herpesvirus 3)Info
PepMix™ VZV (IE62)_2 subpools Pool of 325 peptides (delivered in two subpools of 163 + 162 peptides) derived from a peptide scan through Transcriptional transactivator IE62 of Varicella-zoster virus (strain Oka vaccine)Info
PepMix™ VZV (IE63) Pool of 67 peptides derived from a peptide scan through Transcriptional transactivator IE63 of Varicella-zoster virus (strain Oka vaccine) for T cell assaysInfo
PepMix™ Yellow fever (NS4B) Pool of 60 peptides derived from a peptide scan through Yellow fever Non-structural protein 4B of Yellow fever virus for T cell assaysInfo
PepMix™ Zaire Ebola (GP/Kikwit-95) Pool of 176 peptides derived from a peptide scan through Envelope glyocprotein of Zaire Ebola virus for T cell assays (antigen specific T-cell stimulation)Info
PepMix™ Zaire Ebola (GP/Mayinga-76) Pool of 176 peptides derived from a peptide scan through Envelope glyocprotein of Zaire Ebola virus for T cell assays (antigen specific T-cell stimulation)Info
Positive Control Pool PepMix™ HCMVA (IE-1) Positive Control Pool of 120 peptides derived from a peptide scan through 55 kDa immediate-early protein 1 (IE-1) of Human cytomegalovirus (HHV-5)Info
Positive Control Pool PepMix™ HCMVA (IE-2) Positive Control Pool of 143 peptides derived from a peptide scan through 45 kDa immediate-early protein 2 (IE-2) of Human cytomegalovirus (HHV-5).Info
Positive Control Pool PepMix™ HCMVA (pp65) Positive Control Pool of 138 peptides derived from a peptide scan through 65 kDa phosphoprotein (pp65) of Human cytomegalovirus (HHV-5)Info

Peptide Pools for Tumor Associated Antigens

PepMix™ Arabidopsis (WRKY47) Pool of 120 peptides derived from a peptide scan through Probable WRKY transcription factor 47 of Arabidopsis thaliana (Mouse-ear cress)Info
PepMix™ Human (CEA) Pool of 173 peptides derived from a peptide scan through Carcinoembryonic antigen-related cell adhesion molecule 5 of Homo sapiens (Human)Info
PepMix™ Human (Claudin-6) Pool of 53 peptides derived from a peptide scan through Claudin-6 of Homo sapiens (Human) for T cell assays (antigen specific T-cell stimulation)Info
PepMix™ Human (Cyclin-B1) Pool of 106 peptides derived from a peptide scan through G2/mitotic-specific cyclin-B1 of Homo sapiens (Human) for T cell assays (e.g. ELISPOT)Info
PepMix™ Human (ErbB2_ECD) Pool of 161 peptides derived from a peptide scan through Receptor tyrosine-protein kinase erbB-2 (extracellular domain) of Homo sapiensInfo
PepMix™ Human (ErbB2_ICD) Pool of 146 peptides derived from a peptide scan through Receptor tyrosine-protein kinase erbB-2 (intracellular domain) of Homo sapiens (Human)Info
PepMix™ Human (Histone H1.2) Pool of 51 peptides derived from a peptide scan through Histone H1.2 of Homo sapiens (Human) for T cell assays (antigen specific T-cell stimulation)Info
PepMix™ Human (Histone H4) Pool of 23 peptides derived from a peptide scan through Histone H4 of Homo sapiens (Human) for T cell assays (e.g. antigen specific T-cell stimulation)Info
PepMix™ Human (MAGEA1) Pool of 75 peptides derived from a peptide scan through Melanoma-associated antigen 1 (MAGEA1) of Homo sapiens (Human) for T cell assaysInfo
PepMix™ Human (MAGEA3) Pool of 76 peptides derived from a peptide scan through Melanoma-associated antigen 3 (MAGEA3) of Homo sapiens (Human) for T cell assaysInfo
PepMix™ Human (MAGEA4) Pool of 77 peptides derived from a peptide scan through Melanoma-associated antigen 4 (MAGEA4) of Homo sapiens (Human) for T cell assaysInfo
PepMix™ Human (Mammaglobin A) Pool of 21 peptides derived from a peptide scan through Mammaglobin-A of Homo sapiens (Human) for T cell assays (e.g. ELISPOT)Info
PepMix™ Human (Melan-A/MART-1) Pool of 27 peptides derived from a peptide scan through Melanoma antigen recognized by T-cells 1 (MART-1) of Homo sapiens for T cell assaysInfo
PepMix™ Human (Melanocyte protein Pmel 17 gp100) Pool of 163 peptides derived from a peptide scan through Melanocyte protein Pmel 17 (gp100) of Homo sapiens (Human) for T cell assaysInfo
PepMix™ Human (Metalloreductase STEAP1) Pool of 82 peptides derived from a peptide scan through Metalloreductase STEAP1 of Homo sapiens (Human) for T cell assaysInfo
PepMix™ Human (Mucin-1) Pool of 115 peptides derived from a peptide scan through Mucin-1 of Homo sapiens (Human) for T cell assaysInfo
PepMix™ Human (Myc protein) Pool of 107 peptides derived from a peptide scan through Myc proto-oncogene protein of Homo sapiens (Human) for T cell assaysInfo
PepMix™ Human (NY-ESO-1) Pool of 43 peptides derived from a peptide scan through Cancer/testis antigen 1 (NY-ESO-1) of Homo sapiens for T cell assays (e.g. ELISPOT)Info
PepMix™ Human (P53) Pool of 96 peptides derived from a peptide scan through Cellular tumor antigen p53 of Homo sapiens (Human) for T cell assays (e.g. ELISPOT)Info
PepMix™ Human (PAP) Pool of 94 overlapping peptides from Prostatic acid phosphatase (PAP) of Homo sapiens (human) for T cell assays (e.g. ELISPOT)Info
PepMix™ Human (Prame/OIP4) Pool of 125 peptides derived from a peptide scan through Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) of Homo sapiens (Human)Info
PepMix™ Human (Prostate-specific antigen PSA) Pool of 63 peptides derived from a peptide scan through Prostate-specific antigen of Homo sapiens (Human) for T cell assays (e.g. ELISPOT)Info
PepMix™ Human (SOX-2) Pool of 77 peptides derived from a peptide scan through Transcription factor SOX-2 of Homo sapiens (Human) for T cell assaysInfo
PepMix™ Human (SSX2) Pool of 45 peptides derived from a peptide scan through Protein SSX2 of Homo sapiens (Human) for T cell assays (e.g. ELISPOT)Info
PepMix™ Human (Stromelysin-3, MMP11) Pool of 121 peptides derived from a peptide scan through Stromelysin-3 (MMP11) of Homo sapiens (Human) for T cell assaysInfo
PepMix™ Human (Survivin) Pool of 33 peptides derived from a peptide scan through Baculoviral IAP repeat-containing protein 5 (Survivin) of Human for T cell assaysInfo
PepMix™ Human (TCRgamma alternate reading frame protein TARP) Pool of 12 peptides derived from a peptide scan through TCRgamma alternate reading frame protein of Homo sapiens (Human) for T cell assaysInfo
PepMix™ Human (Tyrosinase) Pool of 117 peptides derived from a peptide scan through Tyrosinase of Homo sapiens (Human) for T cell assays (antigen specific T-cell stimulation)Info
PepMix™ Human (Tyrosinase-related protein 2) Pool of 127 peptides derived from a peptide scan through L-dopachrome tautomerase (Tyrosinase-related protein 2) of Homo sapiens (Human)Info
PepMix™ Human (WT1/WT33) Pool of 110 peptides derived from a peptide scan through Wilms tumor protein (WT33) of Homo sapiens (Human) for T cell assays (e.g. ELISPOT)Info
PepMix™ Mouse (Survivin) Pool of 33 peptides derived from a peptide scan through Baculoviral IAP repeat-containing protein 5 of Mus musculus for T cell assays (e.g. ELISPOT)Info
PepMix™ Mouse (Tyrosinase) Pool of 117 peptides derived from a peptide scan through Tyrosinase of Mus musculus (Mouse) for T cell assays (antigen specific T-cell stimulation)Info

Custom Peptide Pools & Matrix Pools

Custom PepMixes™ Peptide Pools

You need a specific antigen or specialized peptide pool layout?
We are happy to discuss your specifications and provide your tailored PepMix™ or matrix pool. Our customer support team will assist you with peptide scans, sequence and pool design. Subsequently, we will chemically synthesize, purify and analyze the peptides in compliance with the requirements of T-cell assays. All peptide synthesis steps are optimized to avoid contaminations and failure sequences which may lead to false positive T-cell responses or inhibition of T-cell responses.
Pooling and aliquotation are performed using our validated protocols to ensure high quality purified pooled peptides in freeze dried aliquots for long stability.

Custom PepMix™ Production

Custom PepMix Production

Individual ELISPOT Peptides

We are happy to provide the individual peptides to validate results or for follow-up experiments.  Of course, each individual peptide synthesized at JPT is quality controlled according to ISO 9001 standards to ensure batch-to-batch reproducibility!

Please inquire via email!

Applications for PepMix™ Peptide Pools

Benefits of PepMix™ Peptide Pools

Overlapping peptide pools are preferable to whole proteins for antigen-specific T-cell stimulation because:

  • Equivalent or better stimulation of CD4 and CD8 cells
  • More reliable as control than phytohemagglutinin (PHA) and concanavalin A (ConA)
  • Improved responses in stored blood and PBM cells
  • High-batch-to-batch reproducibility
  • Reliable chemical and biochemical quality control and quality assurance for peptide synthesis and peptide pool generation
  • Prolonged shelf stability when stored freeze dried

    Testimonials for PepMix™ Peptide Pools


    "I have used JPT's peptide pools (PepMix™) for years now, with great satisfaction! First CMV derived peptides and now also EBV. So far, we have published data in one publication and plan several more in the near future."

    Anna Karin Lidehaell (Uppsala University, Clin. Immunol., Uppsala, Sweden)

    "The main focus of my research group at the Charité in Berlin is the development of novel immunotherapeutic approaches against cancer and infectious diseases. For reliable monitoring of tumor and virus specific T-cell responses, we have a permanent need for peptide synthesis and peptide pools that are produced in a regulated environment for application in a clinical environment. JPT has been a long term and dedicated partner in this regard, which continuously works on improving it's peptide based services."
    Prof. Dr. Carmen Scheibenbogen, Charité Berlin, Germany

    More testimonials

    Selected References for PepMix™ Peptide Pools


    Control Pools:

    Viral Load, CMV-specific T Cell Immune Response and Cytomegalovirus Disease in Solid Organ Transplant Recipients at Higher Risk for Cytomegalovirus Infection During Preemptive Therapy

    Martín-Gandul et al., Transpl Int. (2014) - PMID: 24964364
    A Registry of HLA-typed Donors for Production of Virus-specific CD4 and CD8 T Lymphocytes for Adoptive Reconstitution of Immune-compromised Patients
    Pira et al., Transfusion. (2014) - PMID: 25041366
    Increased Inflammatory Response in Cytomegalovirus Seropositive Patients with Alzheimer's Disease

    Westmann et al., Plos One (2014) - PMID: 24804776
    Identification and HLA-Tetramer-Validation of Human CD4+ and CD8+ T Cell Responses Against HCMV Proteins IE1 and IE2
    Braendstrup et al., PLOS ONE  (2014) - PMID: 24760079

    Infectious Diseases:

    STAT3 Signaling Contributes to the High Effector Activities of Interleukin-15-derived Dendritic Cells

    Okada et al., Immunol Cell Biol. (2015) - PMID: 25582338
    Superior In Vitro Stimulation of Human CD8+ T-Cells by Whole Virus versus Split Virus Influenza Vaccines
    Halbroth et al., PLoS One (2014) - PMID: PLoS One (2014)
    Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections After HSCT
    Papadopoulou et al., Sci Transl Med. (2014) - PMID: 24964991
    Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
    Fourati et al., JoVE (2014) - PMID: 25046399
    Specificities of Human CD4+ T cell Responses to an Inactivated Flavivirus Vaccine and Infection: Correlation with Structure and Epitope Prediction
    Schwaiger et al., J Virol. (2014) - PMID: 24789782

    Tumor Associated Antigens:
    STAT3 Signaling Contributes to the High Effector Activities of Interleukin-15-derived Dendritic Cells
    Okada et al., Immunol Cell Biol. (2015) - PMID: 25582338
    Common Ewing Sarcoma-associated Antigens Fail to Induce Natural T Cell Responses in Both Patients and Healthy Individuals
    Altvater et al., Cancer Immunol Immunother. (2014) - PMID: 24973179
    The External Quality Assurance Oversight Laboratory (EQAPOL) Proficiency Program for IFN-gamma Enzyme-Linked ImmunoSpot (IFN-ELISpot) Assay
    Sanchez et al.,  J Immunol Methods. (2014) - PMID: n.a.
    Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic Responses
    Weide et al., Cancer Immunology. (2014) - PMID: 24906352
    Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumor Lysate or Homogenate Combined with Immunomodulating Radiotherapy and/or Preleukapheresis IFN-α in Patients with Metastatic Melanoma: a Randomised “Proof-of principle” Phase II Study
    de Rosa et al., J Transl Med. (2014) - PMID: 25053129
    Normalizing ELISPOT Responses to T-cell Counts: a Novel Approach for Quantification of HCMV-Specific CD4+ and CD8+ T-Cell Responses in Kidney Transplant Recipients
    Calarota et al., Journal of Clinical Virology (2014) - PMID: 24961915

    More references

    PepMix

    News Highlights

    Check our brand-new PepMixes™ related to a variety of infections and
    tumor associated antigens, e.g.:
    Human (PAP)
    EBV (BARF1)
    and HPV (L1)
    (February 2014)

    --> Read more news

    Quality Assurance

    All production is performed according to ISO 9001:2008 standards

    TUEV Cert Logo
    Connect